Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study

OBJECTIVE: The effectiveness and safety of sirolimus for SLE treatment have been shown in some uncontrolled studies. However, a comparison of sirolimus with other classic immunosuppressants has not been reported. We conducted the study to compare the effectiveness and safety of sirolimus versus tacr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Nan, Li, Mengtao, Zhang, Hongfeng, Duan, Xinwang, Li, Xiaofeng, Fang, Yongfei, Li, Hongbin, Yang, Pingting, Luo, Hui, Wang, Yanhong, Peng, Liying, Zhao, Jiuliang, Wu, Chanyuan, Wang, Qian, Tian, Xinping, Zhao, Yan, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical Trials and Drug Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724817/
https://www.ncbi.nlm.nih.gov/pubmed/34980680
http://dx.doi.org/10.1136/lupus-2021-000617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724817/
https://www.ncbi.nlm.nih.gov/pubmed/34980680
http://dx.doi.org/10.1136/lupus-2021-000617

Ejemplares similares